Domov › Rakovina hrubého čreva › Maryland
Klinické štúdie Rakovina hrubého čreva v štáte Maryland
22 štúdií pre Rakovina hrubého čreva hľadá účastníkov v zariadeniach v štáte Maryland.
Mestá v štáte Maryland
Oficiálny text štúdie (anglicky)
Family Communications After Genetic Testing
- Sinai Hospital of Baltimore, Baltimore
- Northwest Hospital Center, Randallstown
- UM Saint Joseph Medical Center, Towson
- a 1 ďalších
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07143487Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Christiana Care - Union Hospital, Elkton
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07283939Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
- National Institutes of Health Clinical Center, Bethesda
Prebieha náborFáza 1
Vek 18 až 120 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06885697A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- University of Maryland ( Site 2016), Baltimore
- Greater Baltimore Medical Center ( Site 0068), Baltimore
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06997497Genomic Services Research Program
- National Institutes of Health Clinical Center, Bethesda
Prebieha náborObservačná štúdia
1 Month – 105 Years · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT02595957Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Greater Baltimore Medical Center, Baltimore
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07222800Collection of Blood From Patients With Cancer
- National Institutes of Health Clinical Center, Bethesda
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT00034216A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Saint Agnes Hospital, Baltimore
- Cancer Center For Blood Disorders A Division of American Oncology Partners P.A, Bethesda
- Sarah Cannon Research Institute Scri Oncology Partners, Brandywine
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07284849A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
- University of Maryland Greenbaum, Baltimore
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07058012Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Kaiser Permanente-Woodlawn Medical Center, Baltimore
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg
- Kaiser Permanente - Kensington Medical Center, Kensington
- a 2 ďalších
Prebieha nábor
Vek 45 až 70 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- UM Upper Chesapeake Hematology and Oncology - Aberdeen, Aberdeen
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- a 14 ďalších
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT05174169Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- National Institutes of Health Clinical Center, Bethesda
Prebieha náborFáza 1/2
Vek 18 až 72 · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT03190941KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 7. 2026 · NCT06411691EXoPERT EMERALD Clinical Study
- John Hopkins University, Baltimore
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 45 a viac · Všetky pohlavia · Aktualizované 1. 7. 2026 · NCT07186296Integrated Cancer Repository for Cancer Research
- Northwest Hospital, Randallstown
- William E. Kahlert Regional Cancer Center, Westminster
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Maryland Oncology Hematology, Columbia
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT07011576Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Advanced Molecular Imaging and Therapy, Glen Burnie
- United Theranostics - Chesapeake, Glen Burnie
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 6. 2026 · NCT05283330Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
- National Institutes of Health Clinical Center, Bethesda
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 6. 2026 · NCT00451022Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Johns Hopkins University, Baltimore
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 6. 2026 · NCT06040541Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Johns Hopkins University, Baltimore
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 5. 2026 · NCT05379985Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- GSK Investigational Site, Bethesda
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 1. 2026 · NCT05855200SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- a 1 ďalších
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.